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A b s t r a c t
The GenousTM stent coated with anti-CD34 antibodies has been designed to accelerate healing of the vessel by attracting
circulating endothelial progenitor cells. Rapid restoration of a functional endothelial layer with a full coverage of the stent
struts aims to minimise arterial injury after coronary stenting and to prevent thrombus formation and neointima proliferation.
We report a case of a 56 year-old man who developed a coronary artery aneurysm after the implantation of a GenousTM stent
due to an edge restenosis in sirolimus-eluting stent. We present diagnostics of our patient with the application of intravascular
ultrasound and coronary computed tomography angiography, discuss his management, and hypothesise about the patho-
mechanism of aneurysm formation.
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INTRODUCTION
Coronary artery aneurysm represents an uncommon finding
after coronary balloon angioplasty or stent implantation [1, 2].
It is usually defined as a dilatation of the lumen of a coronary
artery exceeding the diameter of the normal vessel segments
by at least 1.5 times [3]. The natural history and optimal the-
rapy in patients with post intervention coronary artery aneu-
rysm remain unclear.
CASE REPORT
We report the case of a 56 year-old man with hyperlipida-
emia, hypertension, and a history of non-ST-elevation my-
ocardial infarction who was referred to our department due
to anterior ST-elevation acute myocardial infarction with on-
going chest pain of three hours’ duration.
The patient immediately underwent primary percuta-
neous coronary intervention. The culprit lesion was loca-
ted in the proximal segment of the left anterior descen-
ding coronary artery (LAD) (Fig. 1). It was a restenotic le-
sion at the proximal edge of a sirolimus-eluting stent (SES)
implanted three years previously. Coronary angiography
also demonstrated significant stenoses in the middle part
of the LAD and in the right coronary artery (RCA). After
intracoronary administration of abciximab and subsequ-
ent aspiration thrombectomy, a GenousTM stent (OrbusNe-
ich Medical Technologies, Fort Lauderdale, FL, USA) co-
ated with anti-CD34 antibodies (3.5 ¥ 18 mm, 18 atm)
was deployed in the culprit lesion overlapping by about 3 mm
the previously implanted SES. The procedure was unevent-
ful and an excellent immediate angiographic result was
achieved (Fig. 1). Treatment of the other coronary lesions
was scheduled for a second session a few weeks later. The
patient was discharged home in a good condition on the
seventh postprocedural day.
After three months, the patient was readmitted for elec-
tive coronary angioplasties. An aneurysm in the proximal
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LAD at the site of the previous GenousTM stent deployment
was present in coronary angiography performed before the
procedure (Fig. 2). Intravascular ultrasound (IVUS) confir-
med the presence of the aneurysm. Using special software
dedicated to colour imaging of blood flow (Volcano), we
observed blood flow from the lumen of the vessel towards
the aneurysm (Fig. 3). However, there was a filling defect
with intense echogenicity within the aneurysm probably
caused by a residual thrombus. At the same session, the
other coronary lesions were treated with stenting. Angio-
plasty of the middle part of the LAD was completed with
an optimal result, whereas stenting of the RCA was com-
plicated by no-reflow phenomenon and periprocedural
myocardial infarction despite intracoronary abciximab ad-
ministration with restoration of normal epicardial flow.
The patient was discharged from the hospital and a coro-
Figure 1. Critical edge restenosis in a sirolimus-eluting stent (on the left) and immediate effect after the GenousTM stent implanta-
tion (on the right)
Figure 2. A coronary artery aneurysm after the GenousTM stent placement in angiography in RAO and LAO view
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nary computed tomography angiography (CTA) was sche-
duled after eight weeks in order to monitor the coronary
aneurysm.
CTA at eight weeks depicted no progression of the aneu-
rysm and maintained optimal results within the first intraco-
ronary stent (Fig. 4). Since the first admission to our depart-
ment, the patient has been continuing dual antiplatelet the-
rapy with aspirin and clopidogrel. During six months of fol-
low-up, the patient remains asymptomatic.
DISCUSSION
The appearance of angiographic coronary artery aneurysms
after coronary interventions is rare, with a reported incidence
varying between 0.3% and 6.0% [3]. Coronary artery aneury-
sms have been detected from three days to up to four years
after drug-eluting stent (DES) implantation, and from six days
to up to six years after bare metal stent (BMS) placement [4].
To the best of our knowledge, we report for the first time
the development of an aneurysm after the implantation of
Figure 3. A coronary artery aneurysm in intravascular ultrasound. Arrows on the left indicate stent struts. A filling defect with
intense echogenicity linked with the stent struts on the right suggests a thrombus
Figure 4. Computed tomography angiography five months after the GenousTM stent placement. The examination revealed a residu-
al atheromatous plaque with calcification before the stent and no progression of coronary aneurysm (arrows); LAD — left anterior
descending coronary artery; Cx — circumflex coronary artery
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a GenousTM stent coated with anti-CD34 antibodies. The Ge-
nousTM endothelial progenitor cell (EPC) capturing stent is in-
tended to accelerate healing of the vessel by attracting circu-
lating EPCs which mature into endothelial cells and cover the
stent struts to minimise vessel injury after coronary interven-
tion and prevent both thrombosis and restenosis [5].
There are about 30 case reports of aneurysms after DES
in PubMed, mainly concerning sirolimus and paclitaxel [6,
7], one case of an everolimus-eluting stent-related aneurysm
[8], and one case of an aneurysm after a zotarolimus-eluting
stent implantation [6]. The incidence of coronary aneurysms
was similar overall with DES compared to BMS (1.1% [18 of
1,615] with DES and 0.8% [12 of 1,587] with BMS in the
pivotal DES vs BMS randomised trials, in which a routine an-
giographic follow-up was performed six to nine months after
the initial procedure [4]. However, these studies applied a dif-
ferent definition of coronary artery aneurysms as a vessel di-
stension of 20% or more in diameter compared to the refe-
rence vessel. Furthermore, in a real-world setting, most post-
procedural coronary aneurysms are probably never diagno-
sed due to asymptomatic course in the majority of cases.
Residual dissection and deep arterial wall injury (rupture or
resection of the vessel media) caused by oversized balloons or
stents and high-pressure balloon inflations have all been associat-
ed with coronary artery aneurysms after coronary intervention [3].
A possible explanation for the aneurysm in our patient is
the creation of an ulcer and micro-haemorrhage at the site of
the atheromatous plaque during the primary angioplasty. It is
likely that a small dissection, which was not visible on conven-
tional angiography, caused the formation of an ulcer and a mi-
cro-aneurysm. In our case, another possible mechanism for
the aneurysm formation is stent malapposition that occurred
late after the procedure. This phenomenon is observed with
IVUS in about 4% of cases after BMS implantation [9] and in
12.1% of patients after DES stenting [10].
DES delay the healing process secondary to the antipro-
liferative action of the eluting drug, cell necrosis and/or apop-
tosis resulting from the antimetabolite effect of the drug, and
hypersensitivity reactions to the drug/polymer mixture on the
DES [11]. Other reasons for stent malapposition are: regres-
sion of the atheromatous plaque, the incidence of late positi-
ve remodelling (vessel dilatation) at the site of the implanted
stent, allergic reaction to stent components (more common
with DES), and late dissolution of thrombotic material trap-
ped behind the stent struts in case of primary angioplasty [9].
In our case, IVUS showed a filling defect in the aneurysm,
possibly due to a partially dissolved thrombus (Fig. 3).
New generation DES and EPC capturing stents have been
designed to improve the safety profile including the problem
of late acquired stent malapposition. However, in our patient,
stent covered with anti-CD34 antibodies failed to accelerate
the healing process. A large mass of neointima in the critically
restenotic lesion and a high pressure inflation might compress
vasa vasorum in the peristent region and cause local necrosis
of the vessel wall.
We decided to use CTA to follow our patient, mainly to
avoid an invasive coronary artery catheterisation. In some
patients, particularly in asymptomatic ones and those with
small coronary aneurysms, the application of coronary CTA
should be considered as a non-invasive alternative. The effi-
cacy of CTA for identifying coronary artery ectasias and aneu-
rysms has been already proven [12].
The natural history of post-intervention coronary aneu-
rysms appears to be benign in most cases [1, 2]. Aoki et al. [4]
proposed an individualised approach to coronary aneurysms
using a combination of aneurysm size assessed by IVUS,
expansion history, pathophysiology (true or false aneurysm),
and symptoms to decide when and if to apply therapy alter-
natives. Large and symptomatic pseudoaneurysms, rapidly
growing true aneurysms, and especially dangerous infectious
aneurysms should be treated interventionally or surgically to
avoid potentially life-threatening complications regardless of
the stent type implanted. On the other hand, in conservative
management, long-term dual antiplatelet therapy to prevent
stent thrombosis and distal embolism is recommended [4].
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